| P2093 | author name string | Efstathios Kastritis | |
| | Flora Zagouri | |
| | Theodoros N Sergentanis | |
| | Constantine Dimitrakakis | |
| | Maria Gazouli | |
| | Evangelos Terpos | |
| | Spyridon Marinopoulos | |
| | Meletios-Athanasios Dimopoulos | |
| | Eleni Zografos | |
| | Despoina Kalapanida | |
| | Aris Giannos | |
| P2860 | cites work | microRNAs exhibit high frequency genomic alterations in human cancer | Q24546369 |
| | MicroRNAs and triple negative breast cancer | Q26862716 |
| | MicroRNA gene expression deregulation in human breast cancer | Q27860690 |
| | The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 |
| | The miR-34 family in cancer and apoptosis | Q28245865 |
| | Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer | Q28291502 |
| | A microRNA component of the p53 tumour suppressor network | Q28305330 |
| | Triple-Negative Breast Cancer | Q29391607 |
| | Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 |
| | Transcriptional activation of miR-34a contributes to p53-mediated apoptosis | Q29619556 |
| | microRNAs as oncogenes and tumor suppressors | Q29619907 |
| | MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion | Q30352893 |
| | microRNA-34a is tumor suppressive in brain tumors and glioma stem cells | Q30428366 |
| | The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis | Q33618617 |
| | Frequent downregulation of miR-34 family in human ovarian cancers | Q33658229 |
| | MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis | Q33765619 |
| | Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease | Q33769821 |
| | Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans | Q34171160 |
| | Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer | Q34584599 |
| | DNA polymorphisms as modulators of genotoxicity and cancer. | Q34835526 |
| | Quantitative assessment of miR34a as an independent prognostic marker in breast cancer | Q35677744 |
| | The Roles of MicroRNAs in Breast Cancer | Q35818407 |
| | Tumour Necrosis Factor-α Gene Polymorphism Is Associated with Metastasis in Patients with Triple Negative Breast Cancer | Q35844698 |
| | Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3' untranslated region and their association with PARP1 expression in breast cancer patients | Q35919277 |
| | Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population | Q36078898 |
| | MicroRNA: implications for cancer | Q36294667 |
| | Distributions of Hardy-Weinberg equilibrium test statistics | Q36969644 |
| | p53 enters the microRNA world | Q36998341 |
| | The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. | Q37041036 |
| | MicroRNAs: key players in carcinogenesis and novel therapeutic targets. | Q37223100 |
| | Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs | Q37641583 |
| | Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women | Q37692829 |
| | Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort | Q37693410 |
| | MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review). | Q38218967 |
| | The role of microRNAs in human breast cancer progression | Q38221040 |
| | MicroRNAs-mediated cell fate in triple negative breast cancers. | Q38369767 |
| | A rare SNP in pre-miR-34a is associated with increased levels of miR-34a in pancreatic beta cells | Q38555259 |
| | GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population. | Q38666526 |
| | MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5. | Q38715650 |
| | miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis | Q38836817 |
| | Biology and Management of Patients With Triple-Negative Breast Cancer | Q38893074 |
| | Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis | Q39711305 |
| | p53-mediated activation of miRNA34 candidate tumor-suppressor genes. | Q40102003 |
| | Association between the pre-miR-196a2 rs11614913 polymorphism and gastric cancer susceptibility in a Chinese population | Q40676958 |
| | A polymorphism site in the pre‑miR‑34a coding region reduces miR‑34a expression and promotes osteosarcoma cell proliferation and migration | Q41871223 |
| | MiR-34a modulates ionizing radiation-induced senescence in lung cancer cells | Q42378381 |
| | MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. | Q44463289 |
| | A method for meta-analysis of molecular association studies | Q45165474 |
| | miR-34a expression in human breast cancer is associated with drug resistance | Q47139724 |
| | MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma | Q47193877 |
| | Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest | Q48078984 |
| | Emerging roles of microRNAs in cancer | Q50075280 |
| | Impact of microRNA-34a and polymorphism of its target gene CA9 on susceptibility to uterine cervical cancer | Q50181237 |
| | The SNPs in pre-miRNA are related to the response of capecitabine-based therapy in advanced colon cancer patients. | Q50294533 |
| | Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer. | Q51015419 |
| | c-Met and miRs in Cancer. | Q51158233 |
| | The association between common genetic variant of microRNA-499 and cancer susceptibility: a meta-analysis | Q85798687 |
| | Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer | Q85907155 |
| P433 | issue | 97 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 36906-36913 | |
| P577 | publication date | 2018-12-11 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study | |
| P478 | volume | 9 | |